Daewoong of Korea Opens China Lab

Daewoong Pharma, Korea's largest drugmaker, has opened a laboratory in Liaoning that is tasked with working 24/7 to develop oral solutions and solid drugs for China. The lab is part of Liaoning Baifeng, a small China pharma that Daewoong acquired last year. Daewoong has also established corporate offices in Beijing. The company's goal is to achieve $463 million of China revenues in 2020, which it hopes to accomplish through active partnering with local pharmas and academic institutions. More details.... Stock Symbol: (KRX: 069620) Share this with colleagues: // //